Digit
18 known investors
Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
Investors · 18
Fifty YearsSan Francisco · $250K – $2M
A91 PartnersreportedMumbai
Goldman SachsreportedNew York
HSBCreportedLondon
Morgan StanleyreportedPurchase
Steadview CapitalreportedSan Francisco
Also in the syndicate · 12
Abu Dhabi Investment AuthorityAxisBay PondEdelweissFairfax GroupFidelityICICIMirae Asset ManagementPeak XVSBITataTVS Capital
Funding
SEC filings, press & company announcements$3M disclosed across 1 of 3 rounds · 2024–2026
- $3MraisedMar 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Trinity Capital: This May Be The Best Double-Digit Yield In BDC Land (NYSE:TRIN) | Seeking Alphaseekingalpha.com · Aug 2026Frequently asked questions
- What does Digit do?
- Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues. The company applies this measurement technology to discover spatially synergistic tumor antigen targets for immunotherapies and partners with pharmaceutical companies and foundations in precision oncology.
- Who are Digit's investors?
- Digit's investors include Fifty Years, A91 Partners, Goldman Sachs, HSBC, Morgan Stanley, Steadview Capital.
- How much funding has Digit raised?
- Digit has disclosed $3M raised across 1 of its 3 known rounds.